Fig. 3
From: Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Quantification of the microglial motility-related proteins in the three groups. No difference was observed between the AD and control groups for the four proteins (a-d). Significantly increased Iba1 and P2RY12 loads were detected in the iAD vs. AD groups only (P = 0.036 and P = 0.041, respectively) (a-b)